Subhani M, Combs A, Weber P, Gerontis C, DeCristofaro J D
Department of Pediatrics, SUNY at Stony Brook, Stony Brook, New York 11794-8111, USA.
Pediatrics. 2001 Apr;107(4):656-9. doi: 10.1542/peds.107.4.656.
To determine whether significant retinopathy of prematurity (ROP) can be detected before 31 to 33 weeks' postmenstrual age (PMA) in extremely low birth weight (ELBW) infants.
Medical records of all ELBW infants (<1000 g at birth) admitted to our regional perinatal center between April 1995 and January 1999 were reviewed retrospectively. Screening examinations for ROP were routinely performed at 4 to 6 weeks' chronological age (CA) from birth and followed at least every other week. Data were collected for infants who developed ROP. We determined the PMA at which the first screening eye examination demonstrated prethreshold disease and the subsequent examination that showed threshold disease (if it occurred). The percentages of infants who developed prethreshold ROP diagnosed at </=31 weeks' PMA and of those who progressed to threshold ROP before 34 weeks' PMA were determined.
All 258 ELBW infants were screened for ROP. Seventy-eight infants (30%) were diagnosed with prethreshold ROP. Twenty-seven of these infants (35%) progressed to threshold ROP. Ten infants who progressed to threshold ROP were <34 weeks' PMA at the time of this diagnosis. Of these 10 infants, 3 were diagnosed at 31 weeks' PMA, 4 at 32 weeks', and 3 at 33 weeks'.
More than 80% of ELBW infants who developed prethreshold disease in this cohort were </=33 weeks' PMA. The joint statement screening option of independently using 31 to 33 weeks' PMA for the first eye examination would have led to a diagnosis of threshold ROP on first examination in as many as 13% (10/78) of our patients. Early identification of prethreshold ROP is important for providing timely intervention in this rapidly progressive disease. Therefore, ELBW infants should receive initial ROP screening using the CA guideline of 4 to 6 weeks rather than the 31- to 33-week postconceptional age guideline.
确定在极低出生体重(ELBW)婴儿的月经龄(PMA)达到31至33周之前,是否能够检测出严重的早产儿视网膜病变(ROP)。
回顾性分析1995年4月至1999年1月期间入住我们地区围产期中心的所有ELBW婴儿(出生时体重<1000g)的病历。从出生起按实际年龄(CA)4至6周时常规进行ROP筛查检查,之后至少每隔一周进行一次随访。收集发生ROP的婴儿的数据。我们确定首次筛查眼部检查显示阈值前疾病时的PMA以及显示阈值疾病的后续检查(如果发生)。确定在PMA≤31周时被诊断为阈值前ROP的婴儿百分比以及在PMA<34周之前进展为阈值ROP的婴儿百分比。
对所有258例ELBW婴儿进行了ROP筛查。78例婴儿(30%)被诊断为阈值前ROP。其中27例婴儿(35%)进展为阈值ROP。10例进展为阈值ROP的婴儿在诊断时PMA<34周。在这10例婴儿中,3例在PMA 31周时被诊断,4例在32周时被诊断,3例在33周时被诊断。
在该队列中发生阈值前疾病的ELBW婴儿中,超过80%的婴儿PMA≤33周。独立使用31至33周PMA进行首次眼部检查的联合声明筛查方案,在我们多达13%(10/78)的患者中首次检查时会导致阈值ROP的诊断。早期识别阈值前ROP对于在这种快速进展的疾病中提供及时干预很重要。因此,ELBW婴儿应按照4至6周的CA指南而非孕龄31至33周的指南进行初次ROP筛查。